Medisafe Finalist in Reuters Pharma Awards

Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this prestigious award.

The final winners are set to be announced on December 1, 2022, in Philadelphia.

You may also like

Research

Download: Navigating Digital Health Amid Economic Uncertainties

Get the latest insights from industry leaders on how digital technologies and health care delivery can withstand changes in the 

..Read More
Research

Download: Digital Patient Engagement Data

Get the latest insights from industry leaders on how pharma can capture greater value from digital patient programs. Download the 

..Read More
Infographics

Medisafe’s Digital Companion Launch Toolkit

This free launch toolkit has the must-have answers and best practices for all eight stages of a successful digital  launch. 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.